Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want to preserve or improve fertility (or sperm count) and your problem looks like secondary/functional hypogonadism (low T with low/normal LH/FSH): try a SERM that boosts your own testosterone first — enclomiphene (or the commonly used alternative clomiphene/Clomid) is appropriate.
• If you have primary testicular failure (high LH/FSH), need faster/stronger symptom control, or definitely don’t want future fertility, testosterone replacement therapy (TRT) is usually the better choice.

Why they differ (brief)

• Enclomiphene: a SERM that raises GnRH→LH/FSH → stimulates the testes to make more testosterone. It usually preserves or increases sperm production and is useful for secondary hypogonadism. Response takes weeks to months.
• TRT: supplies exogenous testosterone (gels, injections, pellets). It reliably raises serum T and often relieves symptoms faster, but suppresses LH/FSH and usually reduces sperm count (can cause infertility) and has other risks (polycythemia, PSA changes, etc.).

When to consider enclomiphene first

• You want to maintain or improve fertility.
• Your labs show low morning total T with low/normal LH and FSH (suggests central/functional hypogonadism).
• You prefer an oral medication (or to avoid injections/gel) and are willing to wait weeks for effect.
• You and your clinician accept off-label/limited availability issues (see below).

When TRT is more appropriate

• Primary hypogonadism (elevated LH/FSH) — testes cannot respond adequately.
• Severe symptoms needing faster effect, or long-term willingness to be infertile or use sperm preservation.
• Prior failure or intolerance of SERMs.
• Contraindications to SERMs or specific comorbidities favoring TRT after evaluation.

Efficacy and side-effect highlights

• Enclomiphene/clomiphene: can increase endogenous T and maintain/increase sperm counts. Side effects: mood swings, possible changes in vision, increased estradiol/gynecomastia in some men; thrombosis risk is small but theoretical.
• TRT: increases T reliably; side effects include erythrocytosis (monitor hematocrit), acne/oily skin, testicular shrinkage and infertility, possible PSA rise — cardiovascular risk is debated and should be individualized.

Availability and brands/services (names to discuss with your clinician)

• Enclomiphene: frequently discussed as Androxal in literature — availability can be limited; many clinicians use clomiphene citrate (Clomid) off-label for men because it’s widely available and inexpensive.
• TRT products: gels (AndroGel, Testim, Fortesta), intramuscular injections (Depo‑Testosterone/testosterone cypionate; Aveed/testosterone undecanoate), pellets (Testopel).
• Telehealth/men’s clinics that often prescribe TRT (for convenience, not a replacement for specialist care): Roman, Hims, Vault Health — if fertility or diagnostic uncertainty is present, see an endocrinologist or urologist with reproductive experience instead.

Important next steps (practical)

1. Get proper baseline labs: two morning total testosterone measurements (preferably 7–10 AM) on different days, LH, FSH, prolactin, estradiol, CBC, CMP, and PSA if >40 or prostate risk.
2. Review symptoms and fertility plans with an endocrinologist or urologist (or reproductive specialist if fertility is important).
3. If secondary hypogonadism and fertility desired → consider enclomiphene or clomiphene trial with monitoring of T and semen analysis.
4. If primary hypogonadism or fertility not desired → discuss TRT options, dosing, and monitoring (hematocrit, PSA, T levels).

If you want, I can:

• Help interpret your lab results if you share them (with morning times).
• Outline a monitoring schedule for either an enclomiphene/clomiphene trial or TRT.
• Summarize pros/cons of specific TRT formulations for your lifestyle (gels vs injections vs pellets).

Remember: the right choice depends on your labs, symptoms, fertility goals, and medical history — discuss options with a clinician before starting treatment.